Literature DB >> 18486091

Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero.

Shang-Yu Huang1, Ho-Yen Chueh, Sheng-Wen Shaw, Jin-Chung Shih, Po-Jen Cheng.   

Abstract

Mycophenolate mofetil has been shown to have teratogenic properties in animal studies and clinical reports. We report a case of major fetal malformation likely caused by mycophenolate mofetil exposure in utero in a 36 year old patient with systemic lupus erythematosus. The diagnosis was made by ultrasonography at 22 weeks of gestation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486091     DOI: 10.1016/j.ajog.2008.04.008

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Contraception for adolescents with lupus.

Authors:  Melissa S Tesher; Amy Whitaker; Melissa Gilliam; Linda Wagner-Weiner; Karen B Onel
Journal:  Pediatr Rheumatol Online J       Date:  2010-03-31       Impact factor: 3.054

Review 2.  Update on the Teratogenicity of Maternal Mycophenolate Mofetil.

Authors:  Lisa A Coscia; Dawn P Armenti; Ryan W King; Nicole M Sifontis; Serban Constantinescu; Michael J Moritz
Journal:  J Pediatr Genet       Date:  2015-06

3.  Mycophenolate mofetil for ocular inflammation.

Authors:  Ebenezer Daniel; Jennifer E Thorne; Craig W Newcomb; Siddharth S Pujari; R Oktay Kaçmaz; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; C Stephen Foster; Douglas A Jabs; John H Kempen
Journal:  Am J Ophthalmol       Date:  2009-12-30       Impact factor: 5.258

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.